Cargando…

Unmet need for liquid biomarkers and the Brain-Liquid Biopsy Consortium

Detalles Bibliográficos
Autores principales:	Short, Susan C, Noushmehr, Houtan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Supplement Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650471/ https://www.ncbi.nlm.nih.gov/pubmed/36380869 http://dx.doi.org/10.1093/noajnl/vdac020

Ejemplares similares

Advances in molecular biomarkers and liquid biopsy in gliomas
por: Mathios, Dimitrios, et al.
Publicado: (2022)

The future of brain tumor liquid biopsies in the clinic
por: Brennan, Paul M
Publicado: (2022)

OTME-5. Meningioma liquid biopsy specimens exhibit contrasting immune-cell landscapes across methylation-subtypes and estimated recurrence risk subgroups
por: Herrgott, Grayson, et al.
Publicado: (2021)

Liquid biopsy—from bench to bedside
por: Ray, Amitava, et al.
Publicado: (2022)

GEN-7 Liquid biopsy in brain tumor patients -The present and future-
por: Natsumeda, Manabu, et al.
Publicado: (2021)

Paroxysmal nocturnal hemoglobinuria: current treatments and unmet needs
por: Bektas, Meryem, et al.
Publicado: (2020)

Noninvasive approaches to detect methylation-based markers to monitor gliomas
por: Noushmehr, Houtan, et al.
Publicado: (2022)

Ionic liquids for addressing unmet needs in healthcare
por: Agatemor, Christian, et al.
Publicado: (2018)

OTHR-01. Unmet clinical needs in patients with brain metastases in the current treatment era
por: Eggen, Annemarie C, et al.
Publicado: (2021)

Tapping into the genome: the role of CSF ctDNA liquid biopsy in glioma
por: Friedman, Joshua S, et al.
Publicado: (2022)

The Liquid Biopsy Consortium: Challenges and opportunities for early cancer detection and monitoring
por: Batool, Syeda Maheen, et al.
Publicado: (2023)

Circulating tumor cells and extracellular vesicles as liquid biopsy markers in neuro-oncology: prospects and limitations
por: Westphal,, Manfred, et al.
Publicado: (2022)

NQPC-10 (Rare) Cancer patients’ unmet needs (patient-focused healthcare needs) survey
por: Gatellier, Laureline, et al.
Publicado: (2021)

Appropriate use of antibiotics: an unmet need
por: López Romo, Alicia, et al.
Publicado: (2019)

ODP653 DNA Methylation Markers Detected in Liquid Biopsy Specimens Differentiate Pituitary Neuroendocrine Tumors from Other Sellar and CNS Diseases
por: Castro, Ana Valeria, et al.
Publicado: (2022)

TBMT-02. APOLLO: RAMAN-BASED PATHOLOGY OF MALIGNANT GLIOMA
por: Lita, Adrian, et al.
Publicado: (2021)

ML-06 Diagnostic value of liquid biopsy for CNS lymphoma by detection of specific gene mutations in the cerebrospinal fluid
por: Yamagishi, Yuki, et al.
Publicado: (2020)

ML-7 Liquid biopsy for MYD88 mutation in cerebrospinal fluid in patients with suspected primary CNS lymphoma
por: Yuki, Yamagishi, et al.
Publicado: (2021)

The management of neuropsychiatric lupus in the 21st century: still so many unmet needs?
por: Govoni, Marcello, et al.
Publicado: (2020)

Pathogen-focused Clinical Development to Address Unmet Medical Need: Cefiderocol Targeting Carbapenem Resistance
por: Echols, Roger, et al.
Publicado: (2019)

Research-Based Product Innovation to Address Critical Unmet Needs of Patients with Inflammatory Bowel Diseases
por: Honig, Gerard, et al.
Publicado: (2021)

COT-11 Relationship between preoperative liquid biopsy and prognosis of glioblastoma -Next Generation Sequencing of small noncoding RNA-
por: Onishi, Shumpei, et al.
Publicado: (2021)

OMRT-2. Liquid biopsy for patient stratification and monitoring of dacomitinib clinical trial in patients with EGFR amplified recurrent glioblastoma
por: Yekula, Anudeep, et al.
Publicado: (2021)

OTEH-10. Evolutionary trajectory of epigenomic of gliomas
por: Malta, Tathiane, et al.
Publicado: (2021)

Biomarkers and focused ultrasound: the future of liquid biopsy for brain tumor patients
por: Rincon-Torroella, Jordina, et al.
Publicado: (2021)

Liquid biopsies to occult brain metastasis
por: Rehman, Asad Ur, et al.
Publicado: (2022)

Liquid Biopsy and Primary Brain Tumors
por: Eibl, Robert H., et al.
Publicado: (2021)

Liquid biopsy in pediatric brain tumors
por: Tripathy, Arushi, et al.
Publicado: (2023)

Recent progress in treatments of rheumatoid arthritis: an overview of developments in biologics and small molecules, and remaining unmet needs
por: Tanaka, Yoshiya
Publicado: (2021)

Liquid Biopsy Biomarkers in Bladder Cancer: A Current Need for Patient Diagnosis and Monitoring
por: Lodewijk, Iris, et al.
Publicado: (2018)

Liquid Biopsy Potential Biomarkers in Prostate Cancer
por: Neuhaus, Jochen, et al.
Publicado: (2018)

Biomarkers for Liquid Biopsies of Pituitary Neuroendocrine Tumors
por: Gossing, Wilhelm, et al.
Publicado: (2020)

Liquid biopsies for early diagnosis of brain tumours: in silico mathematical biomarker modelling
por: Blee, Johanna A., et al.
Publicado: (2022)

The Role of Liquid Biopsies in Detecting Molecular Tumor Biomarkers in Brain Cancer Patients
por: Sareen, Heena, et al.
Publicado: (2020)

Liquid biopsy in gastric cancer: predictive and prognostic biomarkers
por: Zhang, Zihao, et al.
Publicado: (2022)

Molecular Biomarkers for Adrenoleukodystrophy: An Unmet Need
por: Honey, Madison I. J., et al.
Publicado: (2021)

Recent Advances in Liquid Biopsy of Brain Cancers
por: An, Yunyun, et al.
Publicado: (2021)

Focused Ultrasound-enabled Brain Tumor Liquid Biopsy
por: Zhu, Lifei, et al.
Publicado: (2018)

Liquid Biopsy and Potential Liquid Biopsy-Based Biomarkers in Philadelphia-Negative Classical Myeloproliferative Neoplasms: A Systematic Review
por: Găman, Mihnea-Alexandru, et al.
Publicado: (2021)

Liquid biopsy to identify biomarkers for immunotherapy in hepatocellular carcinoma
por: Ao, Huang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p6duvgip4ouk7fofufple5042e